GeroProteomics

GeroProteomics

(Proteomic study of slowing, stopping, and subverting aging.)

Geroproteomics is the systematic study of age-related changes in the proteome—the entire set of proteins expressed in cells, tissues, or biological fluids—with the goal of understanding, quantifying, and ultimately modulating the biological processes that drive aging and longevity.

Geroproteomics integrates high-throughput proteomic profiling (e.g., mass spectrometry or aptamer-based assays) with aging biology to identify differential protein expression, post-translational modifications, and pathway shifts that correlate with biological age, frailty, or longevity interventions.

Core principles

#
Temporal Proteomic Dynamics — tracking how protein abundance, structure, and turnover evolve across the lifespan.

#
Molecular Signatures of Aging — identifying circulating or tissue proteins (e.g., inflammatory mediators, chaperones, metabolic enzymes) that reflect systemic aging.

#
Pathway Reprogramming — mapping shifts in proteostasis, mitochondrial function, immune signaling, and ECM remodeling that define the transition from youth to senescence.

#
Biological Age Quantification — using machine-learning models trained on proteomic data to estimate biological rather than chronological age.

#
Gerotherapeutic Target Discovery — pinpointing proteins or pathways amenable to pharmacologic or genetic modulation to delay or reverse aging processes.

Conceptual summary

Geroproteomics treats aging as a proteome-level reorganization of systemic homeostasis—a shift from dynamic, energy-efficient, kinase-driven regulation to chronic, compensatory, inflammation-dominated maintenance. It serves as a bridge between genomics (potential) and metabolomics (outcome), providing the most functional, near-real-time reflection of the aging state.

Geromics